Immunity Profiling of COVID-19 Infection, Dynamic Variations of Lymphocyte Subsets, a Comparative Analysis on Four Different Groups
Open Access
- 26 September 2021
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 9 (10), 2036
- https://doi.org/10.3390/microorganisms9102036
Abstract
Background: A novel coronavirus (SARS-CoV-2)-induced pneumonia (COVID-19) emerged in December 2019 in China, spreading worldwide. The aim of the present investigation was to evaluate the immunological response and the clinical subset of peripheral lymphocyte subset alteration in COVID-19 infection. Methods: the study was conducted on four different clinical groups (n = 4; total n = 138). Each individual was assigned to different groups based on specific criteria evaluated at the admission such as fever, dyspnea, arterial blood gas analysis (ABG), oral-nasopharyngeal swab/RT-PCR, and thoracic CT-scan. Treatment was performed only after blood samples were collected from each patient (PP and PP) at day 1. The blood samples were analyzed and tested the same day (CBC and Flowcytometry). The positive–positive group (PP n = 45; F = 18/ M = 27; median age = 62.33), comprised individuals affected by COVID-19 who showed fever, dyspnea (ABG = pO2 < 60), confirmed positive by oral-nasopharyngeal swab/RT-PCR and with CT-scan showing ground-glass opacities. The negative–positive (NP; n = 37; F = 11/M = 26; median age = 75.94) or “COVID-like” group comprised individuals with fever and dyspnea (ABG = pO2 < 60), who tested negative to nasopharyngeal swab/RT-PCR, with CT-scans showing ground-glass opacities in the lungs. The negative–affected group (NA; n = 40; F = 14/M = 26; median age = 58.5) included individuals negative to COVID-19 (RT-PCR) but affected by different chronic respiratory diseases (the CT-scans didn’t show ground-glass opacities). Finally, the negative–negative group (NN; n = 16; F = 14/M = 2) included healthy patients (NN; n = 16; median age = 42.62). Data and findings were collected and compared. Results: Lymphocytes (%) cells showed a decline in COVID-19 patients. The subsets showed a significant association with the inflammatory status in COVID-19, especially with regard to increased neutrophils, T-killer, T-active, T-suppressor, and T-CD8+CD38+ in individuals belong to the either COVID-19 and Covid-like NP group. Conclusions: Peripheral lymphocyte subset alteration was associated with the clinical characteristics and progression of COVID-19. The level of sub-set cells T-lymphocytes (either high or low) and B-lymphocytes could be used as an independent predictor for COVID-19 severity and treatment efficacy.Keywords
This publication has 77 references indexed in Scilit:
- Cytokine Gene Polymorphisms Associate with Microbiogical Agents in Periodontal Disease: Our ExperienceInternational Journal of Medical Sciences, 2014
- The impact of differential antiviral immunity in children and adultsNature Reviews Immunology, 2012
- Selecting a relevant in vitro cell model for testing and comparing the effects of a Choukroun's platelet-rich fibrin (PRF) membrane and a platelet-rich plasma (PRP) gel: Tricks and trapsOral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2010
- Overview of the immune responseJournal of Allergy and Clinical Immunology, 2010
- The decrease of regulatory T cells correlates with excessive activation and apoptosis of CD8+ T cells in HIV‐1‐infected typical progressors, but not in long‐term non‐progressorsImmunology, 2009
- Disappearance of Antibodies to SARS-Associated Coronavirus after RecoveryThe New England Journal of Medicine, 2007
- Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic bloodNature Medicine, 2007
- Science commentary: Th1 and Th2 responses: what are they?BMJ, 2000
- Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin.The Journal of Experimental Medicine, 1996
- CD45 isoforms expression on CD4+ and CD8+ T cells throughout life, from newborns to centenarians: implications for T cell memoryMechanisms of Ageing and Development, 1996